MENS (Jyong Biotech) Volatility: 258.00% (As of Jul. 02, 2026)


MENS Jyong Biotech Ltd MENS
10 GF Score
Price $2.20
! 3 Warning Signs
View Full Analysis

What is Jyong Biotech Volatility?

Jyong Biotech MENS +5.52% 10 Volatility is 258.00% as of Jul. 02, 2026. GuruFocus rates MENS with a GF Score™ of 10/100. The stock has 3 warning signs investors should review.

Volatility is a statistical measure of the dispersion of returns for a given security or market index, it shows how the price swings around its mean. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year. In most cases, the higher the volatility, the riskier the security.

As of today (2026-07-02), Jyong Biotech's Volatility is 258.00%.


Jyong Biotech  (NAS:MENS) Volatility Explanation

Volatility is a statistical measure of the dispersion of returns for a given security or market index. It’s often measured as standard deviation or variance of historical returns over a certain period. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year.

Volatility reflects the uncertainty or risk of a security’s value. Generally speaking, a higher volatility suggests a higher risk, because it implies a wider fluctuation around average price. This means the price of the security can change dramatically in either direction within a short period. Conversely, a lower volatility means that the security's price is more steady, which suggests a lower risk.

Another measurement of relative volatility is Beta. Beta is a measure of systematic risk of a security or a portfolio in comparison to the market as a whole. Beta is usually compared to 1. A beta of greater than 1 indicates that the security's price will be more volatile than the market.


Jyong Biotech Volatility Related Terms


MENS vs ENLV, CNTB, ACOG: Volatility Comparison

For the Biotechnology subindustry, Jyong Biotech's Volatility, along with its competitors' market caps and Volatility data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jyong Biotech Volatility vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jyong Biotech's Volatility distribution charts can be found below:

* The bar in red indicates where Jyong Biotech's Volatility falls into.


MENS
10GF Score
Jyong Biotech Ltd MENS
Volatility is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jyong Biotech  (NAS:MENS) Volatility Calculation

The annualized volatility is calculated as following:

σA=σM * 12
= 1/(n-1) ∑(Ri - R')^2 * 12

Where: σM is the monthly volatility, n is the number of months in the period, Ri is the security's historical monthly returns and R' is the arithmetic mean of monthly returns.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Volatility →
What does a Volatility of 258.00% mean?
Jyong Biotech (MENS) has a Volatility of 258.00% as of Jul. 02, 2026. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on Jyong Biotech and its competitors.
Is Jyong Biotech's Volatility too high?
Jyong Biotech's current Volatility is 258.00%. Overall, Jyong Biotech has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Jyong Biotech's Volatility compare to ENLV and CNTB?
Jyong Biotech's Volatility of 258.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Volatility for a Biotechnology company?
A good Volatility depends on the Biotechnology industry context. However, Volatility should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Volatility mean?
A high Volatility can signal that a stock is expensive relative to its fundamentals. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on Jyong Biotech and its competitors. Jyong Biotech's current Volatility is 258.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jyong Biotech stock overvalued right now?
Jyong Biotech (MENS) has a current Volatility of 258.00%. The current Volatility is 258.00%. Jyong Biotech's overall GF Score™ is 10/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Volatility calculated?
Volatility is calculated from a company's financial statements. For Jyong Biotech (MENS), the current Volatility is 258.00% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jyong Biotech Business Description

Address Xintai 5th Road, 23F-3, No. 95, Section 1, Xizhi district, New Taipei, TWN, 221
Jyong Biotech Ltd is research and develop new drugs for today's great unmet medical needs and planned to manufacture and sell new drugs after receiving regulatory approval. It is a science-driven biotechnology company based in Taiwan and are committed to developing and commercializing and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia. The Group operates and manages its business as a single segment in the research and development of novel therapeutics targeting unmet needs. The company's product pipeline includes MCS-2, PCP, IC.
10GF Score

Get the complete analysis for MENS

Volatility is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.20
Price